Global Prenatal Second-Generation DNA Sequencing Market Research Report 2025

Prenatal Second-Generation DNA Sequencing Market

Prenatal second-generation DNA sequencing refers to the cutting-edge prenatal screening method that uses high-throughput sequencing technology to analyze fetal free DNA in the peripheral blood of pregnant women, in order to detect fetal chromosomal abnormalities and genetic diseases. Compared to invasive examinations such as amniocentesis, this method has significant advantages of non invasiveness and high safety. In terms of clinical application, prenatal second-generation DNA sequencing has expanded from the initial screening for Down syndrome to include screening for sex chromosome abnormalities (such as Turner syndrome, Klinefelter syndrome), microdeletion/microduplication syndrome (such as 22q11.2 deletion syndrome), and some monogenic genetic diseases.

The global market for prenatal second-generation DNA sequencing has shown a thriving trend in recent years. The main driving factors include technological innovation and cost reduction, policy environment optimization, consumer awareness enhancement, and the favor of the capital market. The North American market currently holds a dominant position globally, and its rapid development is attributed to comprehensive healthcare coverage, high medical expenses, and strong consumer demand for advanced prenatal screening. European countries generally adopt strict regulatory policies for prenatal genetic testing, but the market still maintains stable growth under the promotion of precision medicine strategies. The Asia Pacific region has the fastest market growth, mainly driven by policy support, healthcare system upgrades, and other factors. The market competition presents the characteristics of globalization and regionalization coexisting, and various enterprises have adopted differentiated competition strategies based on their own advantages. International leading companies such as Roche, Natera, and Illumina dominate in technology and market, while domestic companies such as BGI Genomics, Berry Genomics, and DAAN Gene are also rapidly rising and actively participating in international competition. In the future, the development trend of the industry mainly lies in the expansion of detection scope, integration of multiple omics, intelligent application of data, forward movement of application scenarios, market segmentation and differentiation, and parallel development of globalization and localization. The market for prenatal second-generation DNA sequencing will enter a mature development stage, with a possible slowdown in growth but deeper applications. Leading enterprises need to shift from technology driven to value driven, not only demonstrating the technical feasibility of testing, but also proving its clinical utility and health economics value. The industry will also face deepening ethical considerations, and how to strike a balance between technological progress and humanistic care will become a proposition that all market participants must consider.

This report aims to provide a comprehensive presentation of the global market for Prenatal Second-Generation DNA Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prenatal Second-Generation DNA Sequencing.

The Prenatal Second-Generation DNA Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prenatal Second-Generation DNA Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prenatal Second-Generation DNA Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Prenatal Second-Generation DNA Sequencing Market Report

Chapter Outline

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Genome Sequencing

1.2.3 Targeted Sequencing

1.3 Market by Application

1.3.1 Global Prenatal Second-Generation DNA Sequencing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 High-Risk Pregnant Women Screening

1.3.3 Twin Pregnancy

1.3.4 Assisted Reproductive Technology Pregnancy

1.3.5 Low-Risk Pregnant Women Screening

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global Prenatal Second-Generation DNA Sequencing Market Perspective (2020-2031)

2.2 Global Prenatal Second-Generation DNA Sequencing Growth Trends by Region

2.2.1 Global Prenatal Second-Generation DNA Sequencing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Prenatal Second-Generation DNA Sequencing Historic Market Size by Region (2020-2025)

2.2.3 Prenatal Second-Generation DNA Sequencing Forecasted Market Size by Region (2026-2031)

2.3 Prenatal Second-Generation DNA Sequencing Market Dynamics

2.3.1 Prenatal Second-Generation DNA Sequencing Industry Trends

2.3.2 Prenatal Second-Generation DNA Sequencing Market Drivers

2.3.3 Prenatal Second-Generation DNA Sequencing Market Challenges

2.3.4 Prenatal Second-Generation DNA Sequencing Market Restraints

3.1 Global Top Prenatal Second-Generation DNA Sequencing Players by Revenue

3.1.1 Global Top Prenatal Second-Generation DNA Sequencing Players by Revenue (2020-2025)

3.1.2 Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Players (2020-2025)

3.2 Global Top Prenatal Second-Generation DNA Sequencing Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Prenatal Second-Generation DNA Sequencing Revenue

3.4 Global Prenatal Second-Generation DNA Sequencing Market Concentration Ratio

3.4.1 Global Prenatal Second-Generation DNA Sequencing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Prenatal Second-Generation DNA Sequencing Revenue in 2024

3.5 Global Key Players of Prenatal Second-Generation DNA Sequencing Head office and Area Served

3.6 Global Key Players of Prenatal Second-Generation DNA Sequencing, Product and Application

3.7 Global Key Players of Prenatal Second-Generation DNA Sequencing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Prenatal Second-Generation DNA Sequencing Historic Market Size by Type (2020-2025)

4.2 Global Prenatal Second-Generation DNA Sequencing Forecasted Market Size by Type (2026-2031)

5.1 Global Prenatal Second-Generation DNA Sequencing Historic Market Size by Application (2020-2025)

5.2 Global Prenatal Second-Generation DNA Sequencing Forecasted Market Size by Application (2026-2031)

6.1 North America Prenatal Second-Generation DNA Sequencing Market Size (2020-2031)

6.2 North America Prenatal Second-Generation DNA Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025)

6.4 North America Prenatal Second-Generation DNA Sequencing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7.1 Europe Prenatal Second-Generation DNA Sequencing Market Size (2020-2031)

7.2 Europe Prenatal Second-Generation DNA Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025)

7.4 Europe Prenatal Second-Generation DNA Sequencing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size (2020-2031)

8.2 Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size by Region (2020-2025)

8.4 Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Prenatal Second-Generation DNA Sequencing Market Size (2020-2031)

9.2 Latin America Prenatal Second-Generation DNA Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025)

9.4 Latin America Prenatal Second-Generation DNA Sequencing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size (2020-2031)

10.2 Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025)

10.4 Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Prenatal Second-Generation DNA Sequencing Introduction

11.1.4 Roche Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Natera

11.2.1 Natera Company Details

11.2.2 Natera Business Overview

11.2.3 Natera Prenatal Second-Generation DNA Sequencing Introduction

11.2.4 Natera Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.2.5 Natera Recent Development

11.3 Illumina

11.3.1 Illumina Company Details

11.3.2 Illumina Business Overview

11.3.3 Illumina Prenatal Second-Generation DNA Sequencing Introduction

11.3.4 Illumina Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.3.5 Illumina Recent Development

11.4 Quest Diagnostics

11.4.1 Quest Diagnostics Company Details

11.4.2 Quest Diagnostics Business Overview

11.4.3 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Introduction

11.4.4 Quest Diagnostics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.4.5 Quest Diagnostics Recent Development

11.5 Ambry Genetics

11.5.1 Ambry Genetics Company Details

11.5.2 Ambry Genetics Business Overview

11.5.3 Ambry Genetics Prenatal Second-Generation DNA Sequencing Introduction

11.5.4 Ambry Genetics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.5.5 Ambry Genetics Recent Development

11.6 PerkinEImer

11.6.1 PerkinEImer Company Details

11.6.2 PerkinEImer Business Overview

11.6.3 PerkinEImer Prenatal Second-Generation DNA Sequencing Introduction

11.6.4 PerkinEImer Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.6.5 PerkinEImer Recent Development

11.7 Invitae

11.7.1 Invitae Company Details

11.7.2 Invitae Business Overview

11.7.3 Invitae Prenatal Second-Generation DNA Sequencing Introduction

11.7.4 Invitae Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.7.5 Invitae Recent Development

11.8 Neogenomics

11.8.1 Neogenomics Company Details

11.8.2 Neogenomics Business Overview

11.8.3 Neogenomics Prenatal Second-Generation DNA Sequencing Introduction

11.8.4 Neogenomics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.8.5 Neogenomics Recent Development

11.9 Agilent Technologies

11.9.1 Agilent Technologies Company Details

11.9.2 Agilent Technologies Business Overview

11.9.3 Agilent Technologies Prenatal Second-Generation DNA Sequencing Introduction

11.9.4 Agilent Technologies Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.9.5 Agilent Technologies Recent Development

11.10 Sema4

11.10.1 Sema4 Company Details

11.10.2 Sema4 Business Overview

11.10.3 Sema4 Prenatal Second-Generation DNA Sequencing Introduction

11.10.4 Sema4 Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.10.5 Sema4 Recent Development

11.11 Thermo Fisher Scientific

11.11.1 Thermo Fisher Scientific Company Details

11.11.2 Thermo Fisher Scientific Business Overview

11.11.3 Thermo Fisher Scientific Prenatal Second-Generation DNA Sequencing Introduction

11.11.4 Thermo Fisher Scientific Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.11.5 Thermo Fisher Scientific Recent Development

11.12 Fulgent Genetics

11.12.1 Fulgent Genetics Company Details

11.12.2 Fulgent Genetics Business Overview

11.12.3 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Introduction

11.12.4 Fulgent Genetics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.12.5 Fulgent Genetics Recent Development

11.13 Genomics England

11.13.1 Genomics England Company Details

11.13.2 Genomics England Business Overview

11.13.3 Genomics England Prenatal Second-Generation DNA Sequencing Introduction

11.13.4 Genomics England Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.13.5 Genomics England Recent Development

11.14 BGI Genomics

11.14.1 BGI Genomics Company Details

11.14.2 BGI Genomics Business Overview

11.14.3 BGI Genomics Prenatal Second-Generation DNA Sequencing Introduction

11.14.4 BGI Genomics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.14.5 BGI Genomics Recent Development

11.15 Berry Genomics

11.15.1 Berry Genomics Company Details

11.15.2 Berry Genomics Business Overview

11.15.3 Berry Genomics Prenatal Second-Generation DNA Sequencing Introduction

11.15.4 Berry Genomics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.15.5 Berry Genomics Recent Development

11.16 DAAN Gene

11.16.1 DAAN Gene Company Details

11.16.2 DAAN Gene Business Overview

11.16.3 DAAN Gene Prenatal Second-Generation DNA Sequencing Introduction

11.16.4 DAAN Gene Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.16.5 DAAN Gene Recent Development

11.17 CapitalBio

11.17.1 CapitalBio Company Details

11.17.2 CapitalBio Business Overview

11.17.3 CapitalBio Prenatal Second-Generation DNA Sequencing Introduction

11.17.4 CapitalBio Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.17.5 CapitalBio Recent Development

11.18 Annoroad

11.18.1 Annoroad Company Details

11.18.2 Annoroad Business Overview

11.18.3 Annoroad Prenatal Second-Generation DNA Sequencing Introduction

11.18.4 Annoroad Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.18.5 Annoroad Recent Development

11.19 MGI Tech

11.19.1 MGI Tech Company Details

11.19.2 MGI Tech Business Overview

11.19.3 MGI Tech Prenatal Second-Generation DNA Sequencing Introduction

11.19.4 MGI Tech Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.19.5 MGI Tech Recent Development

11.20 FANdi Biotechnology

11.20.1 FANdi Biotechnology Company Details

11.20.2 FANdi Biotechnology Business Overview

11.20.3 FANdi Biotechnology Prenatal Second-Generation DNA Sequencing Introduction

11.20.4 FANdi Biotechnology Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.20.5 FANdi Biotechnology Recent Development

11.21 BioMiao Biotechnology

11.21.1 BioMiao Biotechnology Company Details

11.21.2 BioMiao Biotechnology Business Overview

11.21.3 BioMiao Biotechnology Prenatal Second-Generation DNA Sequencing Introduction

11.21.4 BioMiao Biotechnology Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.21.5 BioMiao Biotechnology Recent Development

11.22 JBP Medical

11.22.1 JBP Medical Company Details

11.22.2 JBP Medical Business Overview

11.22.3 JBP Medical Prenatal Second-Generation DNA Sequencing Introduction

11.22.4 JBP Medical Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

11.22.5 JBP Medical Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

 Table 1. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

 Table 2. Key Players of Genome Sequencing

 Table 3. Key Players of Targeted Sequencing

 Table 4. Global Prenatal Second-Generation DNA Sequencing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

 Table 5. Global Prenatal Second-Generation DNA Sequencing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

 Table 6. Global Prenatal Second-Generation DNA Sequencing Market Size by Region (2020-2025) & (US$ Million)

 Table 7. Global Prenatal Second-Generation DNA Sequencing Market Share by Region (2020-2025)

 Table 8. Global Prenatal Second-Generation DNA Sequencing Forecasted Market Size by Region (2026-2031) & (US$ Million)

 Table 9. Global Prenatal Second-Generation DNA Sequencing Market Share by Region (2026-2031)

 Table 10. Prenatal Second-Generation DNA Sequencing Market Trends

 Table 11. Prenatal Second-Generation DNA Sequencing Market Drivers

 Table 12. Prenatal Second-Generation DNA Sequencing Market Challenges

 Table 13. Prenatal Second-Generation DNA Sequencing Market Restraints

 Table 14. Global Prenatal Second-Generation DNA Sequencing Revenue by Players (2020-2025) & (US$ Million)

 Table 15. Global Prenatal Second-Generation DNA Sequencing Market Share by Players (2020-2025)

 Table 16. Global Top Prenatal Second-Generation DNA Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prenatal Second-Generation DNA Sequencing as of 2024)

 Table 17. Ranking of Global Top Prenatal Second-Generation DNA Sequencing Companies by Revenue (US$ Million) in 2024

 Table 18. Global 5 Largest Players Market Share by Prenatal Second-Generation DNA Sequencing Revenue (CR5 and HHI) & (2020-2025)

 Table 19. Global Key Players of Prenatal Second-Generation DNA Sequencing, Headquarters and Area Served

 Table 20. Global Key Players of Prenatal Second-Generation DNA Sequencing, Product and Application

 Table 21. Global Key Players of Prenatal Second-Generation DNA Sequencing, Date of Enter into This Industry

 Table 22. Mergers & Acquisitions, Expansion Plans

 Table 23. Global Prenatal Second-Generation DNA Sequencing Market Size by Type (2020-2025) & (US$ Million)

 Table 24. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Type (2020-2025)

 Table 25. Global Prenatal Second-Generation DNA Sequencing Forecasted Market Size by Type (2026-2031) & (US$ Million)

 Table 26. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Type (2026-2031)

 Table 27. Global Prenatal Second-Generation DNA Sequencing Market Size by Application (2020-2025) & (US$ Million)

 Table 28. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Application (2020-2025)

 Table 29. Global Prenatal Second-Generation DNA Sequencing Forecasted Market Size by Application (2026-2031) & (US$ Million)

 Table 30. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Application (2026-2031)

 Table 31. North America Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

 Table 32. North America Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025) & (US$ Million)

 Table 33. North America Prenatal Second-Generation DNA Sequencing Market Size by Country (2026-2031) & (US$ Million)

 Table 34. Europe Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

 Table 35. Europe Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025) & (US$ Million)

 Table 36. Europe Prenatal Second-Generation DNA Sequencing Market Size by Country (2026-2031) & (US$ Million)

 Table 37. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

 Table 38. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size by Region (2020-2025) & (US$ Million)

 Table 39. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size by Region (2026-2031) & (US$ Million)

 Table 40. Latin America Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

 Table 41. Latin America Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025) & (US$ Million)

 Table 42. Latin America Prenatal Second-Generation DNA Sequencing Market Size by Country (2026-2031) & (US$ Million)

 Table 43. Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

 Table 44. Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025) & (US$ Million)

 Table 45. Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Country (2026-2031) & (US$ Million)

 Table 46. Roche Company Details

 Table 47. Roche Business Overview

 Table 48. Roche Prenatal Second-Generation DNA Sequencing Product

 Table 49. Roche Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 50. Roche Recent Development

 Table 51. Natera Company Details

 Table 52. Natera Business Overview

 Table 53. Natera Prenatal Second-Generation DNA Sequencing Product

 Table 54. Natera Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 55. Natera Recent Development

 Table 56. Illumina Company Details

 Table 57. Illumina Business Overview

 Table 58. Illumina Prenatal Second-Generation DNA Sequencing Product

 Table 59. Illumina Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 60. Illumina Recent Development

 Table 61. Quest Diagnostics Company Details

 Table 62. Quest Diagnostics Business Overview

 Table 63. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product

 Table 64. Quest Diagnostics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 65. Quest Diagnostics Recent Development

 Table 66. Ambry Genetics Company Details

 Table 67. Ambry Genetics Business Overview

 Table 68. Ambry Genetics Prenatal Second-Generation DNA Sequencing Product

 Table 69. Ambry Genetics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 70. Ambry Genetics Recent Development

 Table 71. PerkinEImer Company Details

 Table 72. PerkinEImer Business Overview

 Table 73. PerkinEImer Prenatal Second-Generation DNA Sequencing Product

 Table 74. PerkinEImer Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 75. PerkinEImer Recent Development

 Table 76. Invitae Company Details

 Table 77. Invitae Business Overview

 Table 78. Invitae Prenatal Second-Generation DNA Sequencing Product

 Table 79. Invitae Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 80. Invitae Recent Development

 Table 81. Neogenomics Company Details

 Table 82. Neogenomics Business Overview

 Table 83. Neogenomics Prenatal Second-Generation DNA Sequencing Product

 Table 84. Neogenomics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 85. Neogenomics Recent Development

 Table 86. Agilent Technologies Company Details

 Table 87. Agilent Technologies Business Overview

 Table 88. Agilent Technologies Prenatal Second-Generation DNA Sequencing Product

 Table 89. Agilent Technologies Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 90. Agilent Technologies Recent Development

 Table 91. Sema4 Company Details

 Table 92. Sema4 Business Overview

 Table 93. Sema4 Prenatal Second-Generation DNA Sequencing Product

 Table 94. Sema4 Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 95. Sema4 Recent Development

 Table 96. Thermo Fisher Scientific Company Details

 Table 97. Thermo Fisher Scientific Business Overview

 Table 98. Thermo Fisher Scientific Prenatal Second-Generation DNA Sequencing Product

 Table 99. Thermo Fisher Scientific Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 100. Thermo Fisher Scientific Recent Development

 Table 101. Fulgent Genetics Company Details

 Table 102. Fulgent Genetics Business Overview

 Table 103. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product

 Table 104. Fulgent Genetics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 105. Fulgent Genetics Recent Development

 Table 106. Genomics England Company Details

 Table 107. Genomics England Business Overview

 Table 108. Genomics England Prenatal Second-Generation DNA Sequencing Product

 Table 109. Genomics England Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 110. Genomics England Recent Development

 Table 111. BGI Genomics Company Details

 Table 112. BGI Genomics Business Overview

 Table 113. BGI Genomics Prenatal Second-Generation DNA Sequencing Product

 Table 114. BGI Genomics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 115. BGI Genomics Recent Development

 Table 116. Berry Genomics Company Details

 Table 117. Berry Genomics Business Overview

 Table 118. Berry Genomics Prenatal Second-Generation DNA Sequencing Product

 Table 119. Berry Genomics Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 120. Berry Genomics Recent Development

 Table 121. DAAN Gene Company Details

 Table 122. DAAN Gene Business Overview

 Table 123. DAAN Gene Prenatal Second-Generation DNA Sequencing Product

 Table 124. DAAN Gene Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 125. DAAN Gene Recent Development

 Table 126. CapitalBio Company Details

 Table 127. CapitalBio Business Overview

 Table 128. CapitalBio Prenatal Second-Generation DNA Sequencing Product

 Table 129. CapitalBio Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 130. CapitalBio Recent Development

 Table 131. Annoroad Company Details

 Table 132. Annoroad Business Overview

 Table 133. Annoroad Prenatal Second-Generation DNA Sequencing Product

 Table 134. Annoroad Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 135. Annoroad Recent Development

 Table 136. MGI Tech Company Details

 Table 137. MGI Tech Business Overview

 Table 138. MGI Tech Prenatal Second-Generation DNA Sequencing Product

 Table 139. MGI Tech Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 140. MGI Tech Recent Development

 Table 141. FANdi Biotechnology Company Details

 Table 142. FANdi Biotechnology Business Overview

 Table 143. FANdi Biotechnology Prenatal Second-Generation DNA Sequencing Product

 Table 144. FANdi Biotechnology Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 145. FANdi Biotechnology Recent Development

 Table 146. BioMiao Biotechnology Company Details

 Table 147. BioMiao Biotechnology Business Overview

 Table 148. BioMiao Biotechnology Prenatal Second-Generation DNA Sequencing Product

 Table 149. BioMiao Biotechnology Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 150. BioMiao Biotechnology Recent Development

 Table 151. JBP Medical Company Details

 Table 152. JBP Medical Business Overview

 Table 153. JBP Medical Prenatal Second-Generation DNA Sequencing Product

 Table 154. JBP Medical Revenue in Prenatal Second-Generation DNA Sequencing Business (2020-2025) & (US$ Million)

 Table 155. JBP Medical Recent Development

 Table 156. Research Programs/Design for This Report

 Table 157. Key Data Information from Secondary Sources

 Table 158. Key Data Information from Primary Sources

 Table 159. Authors List of This Report

List of Figures

 Figure 1. Prenatal Second-Generation DNA Sequencing Picture

 Figure 2. Global Prenatal Second-Generation DNA Sequencing Market Size Comparison by Type (2020-2031) & (US$ Million)

 Figure 3. Global Prenatal Second-Generation DNA Sequencing Market Share by Type: 2024 VS 2031

 Figure 4. Genome Sequencing Features

 Figure 5. Targeted Sequencing Features

 Figure 6. Global Prenatal Second-Generation DNA Sequencing Market Size by Application (2020-2031) & (US$ Million)

 Figure 7. Global Prenatal Second-Generation DNA Sequencing Market Share by Application: 2024 VS 2031

 Figure 8. High-Risk Pregnant Women Screening Case Studies

 Figure 9. Twin Pregnancy Case Studies

 Figure 10. Assisted Reproductive Technology Pregnancy Case Studies

 Figure 11. Low-Risk Pregnant Women Screening Case Studies

 Figure 12. Others Case Studies

 Figure 13. Prenatal Second-Generation DNA Sequencing Report Years Considered

 Figure 14. Global Prenatal Second-Generation DNA Sequencing Market Size (US$ Million), Year-over-Year: 2020-2031

 Figure 15. Global Prenatal Second-Generation DNA Sequencing Market Size, (US$ Million), 2020 VS 2024 VS 2031

 Figure 16. Global Prenatal Second-Generation DNA Sequencing Market Share by Region: 2024 VS 2031

 Figure 17. Global Prenatal Second-Generation DNA Sequencing Market Share by Players in 2024

 Figure 18. Global Prenatal Second-Generation DNA Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

 Figure 19. The Top 10 and 5 Players Market Share by Prenatal Second-Generation DNA Sequencing Revenue in 2024

 Figure 20. North America Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 21. North America Prenatal Second-Generation DNA Sequencing Market Share by Country (2020-2031)

 Figure 22. United States Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 23. Canada Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 24. Europe Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 25. Europe Prenatal Second-Generation DNA Sequencing Market Share by Country (2020-2031)

 Figure 26. Germany Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 27. France Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 28. U.K. Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 29. Italy Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 30. Russia Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 31. Nordic Countries Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 32. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 33. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Share by Region (2020-2031)

 Figure 34. China Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 35. Japan Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 36. South Korea Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 37. Southeast Asia Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 38. India Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 39. Australia Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 40. Latin America Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 41. Latin America Prenatal Second-Generation DNA Sequencing Market Share by Country (2020-2031)

 Figure 42. Mexico Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 43. Brazil Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 44. Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 45. Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Share by Country (2020-2031)

 Figure 46. Turkey Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 47. Saudi Arabia Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 48. UAE Prenatal Second-Generation DNA Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 49. Roche Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 50. Natera Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 51. Illumina Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 52. Quest Diagnostics Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 53. Ambry Genetics Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 54. PerkinEImer Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 55. Invitae Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 56. Neogenomics Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 57. Agilent Technologies Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 58. Sema4 Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 60. Fulgent Genetics Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 61. Genomics England Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 62. BGI Genomics Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 63. Berry Genomics Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 64. DAAN Gene Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 65. CapitalBio Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 66. Annoroad Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 67. MGI Tech Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 68. FANdi Biotechnology Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 69. BioMiao Biotechnology Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 70. JBP Medical Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2020-2025)

 Figure 71. Bottom-up and Top-down Approaches for This Report

 Figure 72. Data Triangulation

 Figure 73. Key Executives Interviewed